Daniel Aaron Pollyea
Impact in
- Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 145
- Acute Myeloid Leukemia Research 133
- Chronic Myeloid Leukemia Treatments 31
- Hematopoietic Stem Cell Transplantation 31
- Multiple Myeloma Research and Treatments 21
- Genetics 32
- Chronic Lymphocytic Leukemia Research 18
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11
- Co-authors
- Craig T. Jordan (44 shared papers)Courtney Denton Dinardo (29 shared papers)Brian Andrew Jonas (13 shared papers)Marina Y Konopleva (11 shared papers)Andrew H. Wei (9 shared papers)Clayton A. Smith (30 shared papers)H Kantarjian (11 shared papers)Jalaja Potluri (15 shared papers)
- Journals
- Blood (37 papers)American Journal of Hematology (15 papers)Haematologica (10 papers)Leukemia (7 papers)Bone Marrow Transplantation (7 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Daniel Aaron Pollyea
167 papers receiving 9.1k citations
Daniel Aaron Pollyea's Hit Papers
Peers
Comparison fields: 5 of 108
- Hematology 6.1k
- Genetics 1.5k
- Cancer Research 1.1k
- Molecular Biology 4.3k
- Oncology 1.3k
Countries citing papers authored by Daniel Aaron Pollyea
This map shows the geographic impact of Daniel Aaron Pollyea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Aaron Pollyea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Aaron Pollyea more than expected).
Fields of papers citing papers by Daniel Aaron Pollyea
This network shows the impact of papers produced by Daniel Aaron Pollyea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Aaron Pollyea. The network helps show where Daniel Aaron Pollyea may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Aaron Pollyea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia Hit paper breakdown → | 2018 | 1302 |
| 2 | Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study Hit paper breakdown → | 2018 | 545 |
| 3 | Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia Hit paper breakdown → | 2018 | 523 |
| 4 | OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CML Hit paper breakdown → | 2013 | 425 |
| 5 | Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells Hit paper breakdown → | 2018 | 423 |
| 6 | Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome Hit paper breakdown → | 2018 | 377 |
| 7 | 2016 | 269 | |
| 8 | 2018 | 216 | |
| 9 | NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021 Hit paper breakdown → | 2021 | 215 |
| 10 | 2017 | 212 | |
| 11 | 2020 | 206 | |
| 12 | 2017 | 196 | |
| 13 | 2019 | 174 | |
| 14 | 2019 | 131 | |
| 15 | 2011 | 123 | |
| 16 | 2019 | 117 | |
| 17 | 2020 | 117 | |
| 18 | 2019 | 115 | |
| 19 | 2020 | 110 | |
| 20 | 2021 | 106 |
About Daniel Aaron Pollyea
Daniel Aaron Pollyea is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Public Health, Environmental and Occupational Health, having authored 177 papers that have together received 9.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (133 papers), Histone Deacetylase Inhibitors Research (35 papers), Chronic Myeloid Leukemia Treatments (31 papers), Hematopoietic Stem Cell Transplantation (31 papers), Acute Lymphoblastic Leukemia research (26 papers), Multiple Myeloma Research and Treatments (21 papers), Chronic Lymphocytic Leukemia Research (18 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers). The work is most often cited by research in Hematology (6.1k citations), Genetics (1.5k citations), Cancer Research (1.1k citations), Molecular Biology (4.3k citations) and Oncology (1.3k citations). Daniel Aaron Pollyea has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Craig T. Jordan, Courtney Denton Dinardo, Brian Andrew Jonas, Marina Y Konopleva, Andrew H. Wei, Clayton A. Smith, H Kantarjian, Jalaja Potluri, Brett M. Stevens and Brenda Chyla. Their work appears in journals such as Blood, American Journal of Hematology, Haematologica, Leukemia and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.